LATEST NEWS: Weight loss plan better than usual diet for diabetes patients - NEW YORK (Reuters Health) - A commercial diet plan that includes prepackaged foods, menu plans and access to counselors was better at helping people with type 2 diabetes shed pounds than a typical diet, according to a new study.
LATEST NEWS: Valeant CEO 'disappointed' in Allergan poison pill: CNBC - (Reuters) - The chief executive officer of Valeant Pharmaceuticals, which made a $47 billion unsolicited offer for competitor Allergan Inc on Tuesday, said during an interview on CNBC that he was "disappointed" with Allergan's so-called poison pill.
LATEST NEWS: Aspirin's benefit in preventing colon cancer depends on DNA - NEW YORK (Reuters) - Cancer is the first disease where physicians have personalized treatment, matching a tumor's genetics to the appropriate chemotherapy, and now it may be the first in which prevention, too, can be personalized.
LATEST NEWS: Could shared sex toys transmit HPV? - NEW YORK (Reuters Health) - Women with the potentially cancer-causing human papillomavirus, or HPV, may be putting their partners at risk if they share sex toys during intimate relations, a new study suggests.
LATEST NEWS: California bill to curb medical marijuana passes key hurdle - SACRAMENTO, California (Reuters) - A measure to regulate California's chaotic medical marijuana industry passed a key legislative hurdle on Tuesday, in a move that could lay the groundwork to tax and control recreational use of the drug if it ultimately becomes legal.
LATEST NEWS: Valeant, Ackman offer to buy Botox maker Allergan for $47 billion - (Reuters) - Canada's Valeant Pharmaceuticals International Inc said on Tuesday it and activist investor Bill Ackman made an unsolicited $47 billion bid to buy Botox maker Allergan Inc as it seeks to become one of the world's five biggest drug companies.